Dr Reddys Laboratories (RDY) Equity Ratio (2022 - 2025)
Dr Reddys Laboratories (RDY) has 2 years of Equity Ratio data on record, last reported at 22.33 in Q1 2023.
- For Q1 2023, Equity Ratio rose 17.55% year-over-year to 22.33; the TTM value through Mar 2024 reached 8.62, up 52.65%, while the annual FY2023 figure was 22.33, 17.55% up from the prior year.
- Equity Ratio reached 22.33 in Q1 2023 per RDY's latest filing, up from 19.0 in the prior quarter.
- Across five years, Equity Ratio topped out at 22.33 in Q1 2023 and bottomed at 19.0 in Q1 2022.